Literature DB >> 20587676

Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment.

Wade D Rich1, Kathy J Auten, Marie G Gantz, Ellen C Hale, Angelita M Hensman, Nancy S Newman, Neil N Finer.   

Abstract

OBJECTIVES: The purposes of this study were to quantify the time and effort involved in obtaining prenatal consent for the Neonatal Research Network Surfactant Positive Airway Pressure and Pulse Oximetry Randomized Trial (SUPPORT) and to determine whether the enrolled infants were representative of the eligible population.
METHODS: Eligible subjects were likely to deliver in the SUPPORT gestational age window (24-27(6/7)] weeks). Data included who approached the subjects for consent, how often they approached, the duration of each contact, whether consent was obtained, and whether subjects were enrolled in the trial. Eligible, nonenrolled infants entered into the Neonatal Research Network Generic Database throughout the period of SUPPORT enrollment were compared with enrolled infants.
RESULTS: A total of 2826 women were identified at 18 sites, 2228 were approached for consent, and 1219 (54.7%) agreed. For 76.9% of those approached, <3 visits (mean: 2.0 +/- 1.2 visits) were required to complete the consent process. Of the 659 infants with consent who were delivered within the study window, 611 were enrolled. Mothers who received a neonatal consultation were more likely to give consent (P < .001). The proportion of infants not exposed to steroids was significantly greater in the nonapproached group than in the approached group (20.0% vs 3.4%; P < .0001).
CONCLUSION: In a trial that involved preterm infants and required prenatal consent, >5 women were identified as being likely to deliver in the SUPPORT gestational age window for each 1 who delivered an enrolled infant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20587676      PMCID: PMC3057215          DOI: 10.1542/peds.2009-3353

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

Review 1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

Authors:  D Moher; K F Schulz; D Altman
Journal:  JAMA       Date:  2001-04-18       Impact factor: 56.272

2.  Presumed consent in emergency neonatal research.

Authors:  D J Manning
Journal:  J Med Ethics       Date:  2000-08       Impact factor: 2.903

3.  What do parents think about enrolling their premature babies in several research studies?

Authors:  C J Morley; R Lau; P G Davis; C Morse
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

4.  Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a controlled study.

Authors:  S C Harth; Y H Thong
Journal:  BMJ       Date:  1990-05-26

5.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

6.  The myth of informed consent: in daily practice and in clinical trials.

Authors:  W A Silverman
Journal:  J Med Ethics       Date:  1989-03       Impact factor: 2.903

7.  Applying results of randomised trials to clinical practice: impact of losses before randomisation.

Authors:  M E Charlson; R I Horwitz
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

Review 8.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  D Roberts; S Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

9.  Sample bias among women with retained DNA samples for future genetic studies.

Authors:  Kjersti Aagaard-Tillery; Baha Sibai; Catherine Y Spong; Valerija Momirova; George Wendel; Katharine Wenstrom; Philip Samuels; Margaret Cotroneo; Atef Moawad; Yoram Sorokin; Menachem Miodovnik; Paul Meis; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2006-11       Impact factor: 7.661

10.  Systematic bias introduced by the informed consent process in a diagnostic research study.

Authors:  Alice M Mitchell; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2008-03       Impact factor: 3.451

View more
  25 in total

1.  Enrollment of extremely low birth weight infants in a clinical research study may not be representative.

Authors:  Wade Rich; Neil N Finer; Marie G Gantz; Nancy S Newman; Angelita M Hensman; Ellen C Hale; Kathy J Auten; Kurt Schibler; Roger G Faix; Abbot R Laptook; Bradley A Yoder; Abhik Das; Seetha Shankaran
Journal:  Pediatrics       Date:  2012-02-27       Impact factor: 7.124

2.  Quality improvement ethics: lessons from the SUPPORT study.

Authors:  Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2013       Impact factor: 11.229

Review 3.  Unproven therapies in clinical research and practice: the necessity to change the regulatory paradigm.

Authors:  Susan H Wootton; Patricia W Evans; Jon E Tyson
Journal:  Pediatrics       Date:  2013-09-16       Impact factor: 7.124

4.  Use of antihypotensive therapies in extremely preterm infants.

Authors:  Beau Batton; Lei Li; Nancy S Newman; Abhik Das; Kristi L Watterberg; Bradley A Yoder; Roger G Faix; Matthew M Laughon; Barbara J Stoll; Krisa P Van Meurs; Waldemar A Carlo; Brenda B Poindexter; Edward F Bell; Pablo J Sánchez; Richard A Ehrenkranz; Ronald N Goldberg; Abbot R Laptook; Kathleen A Kennedy; Ivan D Frantz; Seetha Shankaran; Kurt Schibler; Rosemary D Higgins; Michele C Walsh
Journal:  Pediatrics       Date:  2013-05-06       Impact factor: 7.124

5.  Delivery room research: when does poor quality evidence become an ethical issue?

Authors:  Elizabeth E Foglia; Louise S Owen; Haresh Kirpalani
Journal:  Pediatrics       Date:  2015-05       Impact factor: 7.124

Review 6.  When is waiver of consent appropriate in a neonatal clinical trial?

Authors:  Mark S Schreiner; Dalia Feltman; Thomas Wiswell; Susan Wootton; Cody Arnold; Jon Tyson; John D Lantos
Journal:  Pediatrics       Date:  2014-10-06       Impact factor: 7.124

7.  Hope vs. caution: ethical and regulatory considerations for neonatal stem cell therapies.

Authors:  Naomi T Laventhal; Scott A Rivkees; Valerie P Opipari
Journal:  Pediatr Res       Date:  2018-01-10       Impact factor: 3.756

8.  Use of altered informed consent in pragmatic clinical research.

Authors:  Ross E McKinney; Laura M Beskow; Daniel E Ford; John D Lantos; Jonathan McCall; Bray Patrick-Lake; Mark J Pletcher; Brian Rath; Hollie Schmidt; Kevin Weinfurt
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

9.  Resuscitation of preterm neonates with limited versus high oxygen strategy.

Authors:  Vishal S Kapadia; Lina F Chalak; John E Sparks; James R Allen; Rashmin C Savani; Myra H Wyckoff
Journal:  Pediatrics       Date:  2013-11-11       Impact factor: 7.124

Review 10.  Perinatal management: What has been learned through the network?

Authors:  Sanjay Chawla; Elizabeth E Foglia; Vishal Kapadia; Myra H Wyckoff
Journal:  Semin Perinatol       Date:  2016-08-01       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.